Cardurion Pharmaceuticals Announces Formation of Scientific and Clinical Advisory Board
CAMBRIDGE, MASS. – [June 26, 2018] – Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today announced that it has assembled world-class Scientific and Clinical Advisory Boards. “Cardiovascular disease is the leading cause of death in both men and women and accounts for one-third of […]
